Torrid Holdings Inc. (CURV) is a specialty apparel retailer focused on plus-size and mid-size women's fashion, selling through its e-commerce platform and retail stores under the Torrid, Torrid Curve, CURV, and Lovesick brands. The question of whether the stock can reach a $2.85 price target requires weighing a rare and unusually wide split among Wall Street analysts.
Torrid's coverage is thin, and the targets are unusually dispersed. Recent verified numeric targets include Bank of America Securities, which raised its target to $2.70 from $2.25 and kept a Buy rating in September 2026; Telsey Advisory, which lifted its target to $3.00 from $2.00 while maintaining a Hold; Morgan Stanley, which resumed coverage at Equal Weight with a $1.80 target in July 2026; and Goldman Sachs, which maintained a Sell with a $0.75 target. Several firms, including William Blair and BTIG, rate the shares but do not publish numeric targets.
Because the overall mean of these four numeric targets — about $2.06 — sits below the current price, it is not a useful basis for a forward-looking target. The $2.85 figure used here is therefore the average of the two verified targets above the current price: $2.70 and $3.00. The full range, roughly $0.75 to $3.00, reflects a genuine divergence between analysts who see a cost-cutting-led recovery and those who see a shrinking, tariff-exposed business.
Torrid shares traded around $2.45 in mid-October 2026, near the upper portion of a 52-week range spanning roughly $0.94 to $2.86. Reaching $2.85 would require an advance of about 16% from that level, which qualifies as a substantial move for a small-cap retailer with a market capitalization of roughly $260 million.
The company has been restructuring, closing underperforming stores and cutting costs to protect margins against declining sales. Its fiscal second-quarter report in early September 2026 showed a revenue miss and a small net loss, though analysts noted improving EBITDA visibility. Bank of America raised its fiscal 2026 EBITDA estimate to $77 million and its fiscal 2027 estimate to $84.4 million following that report, a sign that margin execution is improving even as the top line remains soft.
The most credible support comes from margin recovery rather than growth. Management's cost reductions and store rationalization could lift profitability even if revenue stays flat to down. Analysts project a return to modestly positive EPS (earnings per share) in the coming fiscal year. A firmer consumer backdrop, easing inflation, tariff relief, and resilient labor-market conditions were cited by Morgan Stanley as broadly supportive of specialty retail. Because the float is small and short interest is elevated at roughly 11% of the float, any sustained positive news flow could also trigger short covering that amplifies an upward move.
The principal obstacle is the revenue trajectory. Sales have declined year over year, and the company continues to close stores, which reduces its long-term sales base. Tariff exposure on imported apparel adds cost pressure, while a cautious consumer weighs on discretionary spending. The valuation argument is contested: analysts with Sell or cautious ratings argue the shares already price in much of the expected margin improvement. With a wide target range and an overall mean below the current price, the Street is clearly not aligned behind a meaningful advance.
The $2.85 target sits essentially at the stock's 52-week high of about $2.86, a meaningful resistance level that has capped the rally. A decisive move above that zone would represent a breakout from the range the shares have traded in since recovering from their December 2025 low near $0.94. On the downside, the $2.20 to $2.25 area served as a consolidation zone during mid-2026, while the round $2.00 level is a psychological support. The long-term structure remains deeply damaged from the 2021 high above $33, so the shares are best viewed within a recovery, not an uptrend, context.
Analyst price targets generally reflect a roughly 12-month research horizon, though individual firms differ. For Torrid, the next earnings release is expected around December 9, 2026, and it will be pivotal for confirming whether margin gains are translating into earnings. Investors should also track quarterly comparable sales, store-closure progress, tariff policy developments, any further analyst revisions, and changes in the elevated short interest, all of which can move a thinly traded, heavily shorted stock more sharply than the broader market.
For traders seeking a systematic way to track setups like this, Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. This can help traders discover opportunities, monitor existing positions, and spot shifting trends more efficiently than manual screening alone. Explore the tool to see how AI-based signals can fit into your own research process.
The $2.85 target is a legitimate but selectively derived figure: it is the average of the two analyst targets that sit above the current price, not a broad consensus. It represents about 16% upside and coincides with the 52-week high, making it a demanding level that would require a technical breakout as well as continued margin execution. The strongest support is the company's cost-cutting and improving EBITDA outlook; the biggest obstacles are falling revenue, store closures, and tariff exposure. With the overall analyst mean still below the current price and a target range stretching from $0.75 to $3.00, the central case is genuinely contested. Investors should focus on the December earnings report and any changes in analyst revisions and short interest before drawing conclusions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, CURV has been loosely correlated with DBI. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CURV jumps, then DBI could also see price increases.
| Ticker / NAME | Correlation To CURV | 1D Price Change % | ||
|---|---|---|---|---|
| CURV | 100% | -6.27% | ||
| DBI - CURV | 39% Loosely correlated | -4.07% | ||
| GCO - CURV | 33% Poorly correlated | -2.90% | ||
| SHOE - CURV | 31% Poorly correlated | -3.27% | ||
| GAP - CURV | 29% Poorly correlated | -1.04% | ||
| BKE - CURV | 26% Poorly correlated | -2.30% | ||
More | ||||